When Kathryn Harkup talks about Agatha Christie, it is rarely just about literature. Very quickly, chemistry moves into the foreground: active ingredients, doses, and side effects. The British chemist and science communicator has specialized precisely in this intersection. In her lectures, she shows how closely the author Agatha Christie (1890-1976) tied her crime plots to real pharmaceutical knowledge. That helps explain why her murders still feel so plausible today. Behind the suspense lies experience.

Harkup develops this point in the lecture with concrete examples. Christie did not write from pure imagination. During World War I, she began as a nurse and soon moved to the hospital pharmacy. There she no longer stood at the bedside but at the pharmacy scales: She prepared medicines, measured active ingredients, and worked from prescriptions. It was there that she learned how narrow the margin between an effective and a dangerous dose can be — and how quickly small deviations can have major consequences.

That practical experience is visible in Christie’s writing. Many of her plots are based on principles familiar from pharmacotherapy. This is particularly interesting for a medical audience because clinical knowledge and literary construction are closely intertwined.

Where Dosage Determines Life and Death

Christie’s training fell into a time of upheaval. The switch from the imperial to the metric system required precise calculation. A misplaced decimal point could multiply a dose by 10. This experience shaped her understanding of medicines profoundly. She grasped early on that every substance can be toxic; the crucial factor is the amount.

In her stories Christie deliberately uses this principle. Often it is not the substance itself but the dose that decides. For physicians, this will be familiar: Many drugs have a narrow therapeutic window, and small deviations can have major consequences.

Characteristic of her treatment of substances is that she uses real active ingredients rather than invented poisons and bases her work on their known effects. That gives her stories a remarkable plausibility.

Strophanthin: A Heart Medication With Risk

A particularly telling example is strophanthin, a potent steroidal cardiac glycoside derived from African Strophanthus species. Pharmacologically, it acts on the sodium-potassium ATPase — a central transporter in cardiac muscle cells. When this is inhibited, the sodium balance shifts and intracellular calcium levels later rise. The result is stronger contractions and increased pumping performance — an effect that can be used therapeutically but that quickly tips into toxicity.

Therapeutically, this effect can be useful in heart failure. But the therapeutic index is small. Even slight overdoses lead to arrhythmias and, in extreme cases, cardiac arrest. Christie uses this property in her story “The Case of the Caretaker,” included in Miss Marple’s Final Cases (1979). There, strophanthin is deliberately injected to produce an apparently natural death. A comparison with digoxin explains why strophanthin did not gain broad clinical use. Digoxin can be given orally and is easier to manage; strophanthin typically requires parenteral administration. Despite its high potency, strophanthin, therefore, remained a marginal therapeutic agent.

For clinical practice, this example underlines the risks for highly potent cardiac drugs: A small excess dose can have dramatic consequences. Christie’s literary construction may seem exaggerated, but it captures the pharmacologic core with surprising accuracy.

Nitroglycerin: Vasodilation With Side Effects

In “The Chocolate Box,” from Poirot’s Early Cases (1974), nitroglycerin plays a central role. The compound was first synthesized in 1847 by Ascanio Sobrero (1812-1888) and later industrially exploited by Alfred Nobel (1833-1896). Medically, it has been used since the 19th century to treat angina pectoris.

In the body, nitroglycerin is converted to nitric oxide, which causes relaxation of vascular smooth muscle. Vessels dilate, blood flow improves, and myocardial oxygen demand decreases. Clinically, this effect is well established.

Christie constructs a murder by hiding tablets containing an excessive dose of nitroglycerin in chocolate. That at first seems plausible, but the amount required would be very large; a lethal effect from nitroglycerin alone is therefore unlikely. Only in combination with alcohol could a critical drop in blood pressure occur.

This combination is what makes the case medically interesting. Alcohol enhances the vasodilating effect and can exacerbate hypotension. Christie thus uses a real pharmacodynamic interaction, even if she treats the dosing question generously.

Chloral Hydrate: Sedation and Respiratory Depression

With chloral hydrate Christie turns to a substance long used as a sedative. In “Passenger to Frankfurt” (1970), it appears as a classic “knockout” agent. Pharmacologically, it acts through GABAergic mechanisms in the central nervous system.

The substance enhances inhibitory signaling pathways, leading to sedation. However, with increasing doses, the respiratory center can also be suppressed. The combination with alcohol is particularly problematic: Both have an additive effect, potentially leading to respiratory depression in the worst-case scenario.

A look at history shows the substance’s double role. Chloral hydrate was used both in medicine and in criminal contexts. Its relatively easy administration favored abuse, while it was at the same time used therapeutically for sedation. Today, chloral hydrate plays only a minor role; modern sedatives offer better control and safety. Nonetheless, the agent remains a clear example of the risks for centrally acting drugs, especially when combined with other depressant substances.

Boomslang Venom: When Coagulation Fails

In “Death in the Clouds” (1935), Christie turns to an unusual poison: the venom of the boomslang snake. This venom contains enzymes that profoundly interfere with blood coagulation. The result is disseminated intravascular coagulation: Initially, the blood clots excessively, and then clotting factors are depleted and the system collapses. This leads to hematomas, mucosal bleeding, and finally internal bleeding. Without treatment, this course can be fatal. The underlying mechanism corresponds to what is now known about hemotoxic snake venoms.

Christie accelerates the effect by having the venom introduced directly into a blood vessel; symptoms therefore appear much faster. Some details, such as the rapid identification of the venom, seem implausible from a modern perspective. The pathophysiologic core, however, remains coherent.

For clinicians, the central point becomes clear: The appropriate antivenom is crucial. Nonspecific measures are often insufficient. At the same time, a practical problem is evident — availability of these antivenoms is limited, and time is critical.

This story was translated from Univadis Germany, part of the Medscape Professional Network.